Dialysis Catheter Market Size, Share, Growth, and Industry Analysis, By Type (Long-Term Hemodialysis Catheter, Short-Term Hemodialysis Catheter and Others) By Application (Dialysis Centers, Hospitals, Homecare Settings and Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

DIALYSIS CATHETER MARKET OVERVIEW

The global dialysis catheter market was value at USD 0.92 Billion in 2026 and reaching USD 1.33 Billion by 2035 with a projected CAGR of 4.2% from 2026 to 2035.

A hemodialysis machine and a patient's blood are exchanged through a dialysis catheter. Dialysis is a process that clears the blood of extra fluid and waste products. Blood is typically filtered by the kidneys by eliminating extra fluid and waste from the blood. The bladder receives this waste after which it is ultimately expelled by urine. Extra waste, water, and other pollutants are prevented from building up in the body by functioning kidneys. The function of the kidneys also includes controlling blood pressure and the amount of chemical substances in the blood. Potential chemical components include salt and potassium. If the kidneys are not functioning, dialysis fills in for them.

Since the 1940s, dialysis has been utilised as a form of treatment for kidney disease. Hemodialysis and peritoneal dialysis are the two main forms of dialysis. During peritoneal dialysis, excess fluid and waste products are eliminated from the body by using a fluid called dialysate. The patient's abdominal cavity receives the dialysate. Hemodialysis is a technique that eliminates waste, excess fluid, and toxins from the body using an artificial kidney (hemodialyzer). The most popular form of dialysis is hemodialysis. The procedure is carried out three times per week and usually lasts three to five hours.

KEY FINDINGS

COVID 19 IMPACT

Emphasize on Treating COVID-19 Patients Encumbered the Market Growth

The consequence of the COVID-19 pandemic had a negative impact on the dialysis catheter market share. Underlined and heightened the necessity of patients suffering from COVID-19 the hospitals and medical centers got more focused on treating them, henceforth resulting in the delay or postponing in dialysis procedures. As a result, it caused a decline to the dialysis catheter market growth during the forecaster period.

LATEST TRENDS

Technological Advancements in Healthcare to Attract the Market Share

The market has changed in established nations, while emerging markets provide significant room for expansion. In order to improve the quality of life for patients, players are now concentrating on increasing the number of dialysis facilities, developing treatment modalities, and implementing novel technology in renal dialysis products. The prevalence of Chronic Kidney Disorders (CKDs), technological advancements such as the creation of catheters with anti-microbial coatings, and other reasons are also driving the market.

• According to the United States Renal Data System (USRDS) under the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 80.5% of incident hemodialysis patients in the U.S. started dialysis using a catheter as the initial vascular access. This reflects the continued reliance on dialysis catheters during the early stages of renal replacement therapy when permanent access such as fistulas are not yet available. The high proportion of first-treatment catheter use indicates an ongoing demand for advanced dialysis catheter designs that allow rapid access and improved blood flow during emergency dialysis initiation.
• According to data from the Centers for Medicare & Medicaid Services (CMS) Dialysis Facility Reports, around 23.3% of prevalent hemodialysis patients were using catheters as their vascular access in 2023, while 57.2% used arteriovenous fistulas. This measurable presence of catheter-based access demonstrates the sustained role of tunneled dialysis catheters in patients who cannot undergo fistula or graft procedures, supporting ongoing innovations in antimicrobial coatings, tip configurations, and lumen designs.

Download Free Sample to learn more about this report

DIALYSIS CATHETER MARKET SEGMENTATION

By Type

Based on type the market is classified into long-term hemodialysis catheter, short-term hemodialysis catheter and others.

Long-term hemodialysis catheter is the leading type of the segment in the market.

By Application

Based on application the market is classified as dialysis centers, hospitals, homecare settings and others.

The dialysis centers accounts for the leading application in the market.

DRIVING FACTORS

Rise in Prevalence and Incidence of Kidney Diseases to Drive the Demand

Demand for dialysis catheters is anticipated to increase along with the prevalence and incidence of renal illnesses. The National Chronic Kidney Disease Fact Sheet projects that 30 million Americans, or 15% of the adult population, will have chronic kidney disease by 2017. Of these, 48% of those with significantly diminished kidney function are unaware that they have chronic renal disease. Women are thought to experience chronic renal disease more frequently than males.

• According to the United States Renal Data System (USRDS), more than 533,945 adult patients were receiving hemodialysis treatment in the United States in 2024. Since every hemodialysis procedure requires vascular access and a significant portion of patients rely on catheters, the expanding ESRD patient pool directly increases the demand for dialysis catheter devices in hospitals and dialysis centers.
• According to the Healthy People 2030 initiative led by the U.S. Department of Health and Human Services, 16.7% of adult dialysis patients relied exclusively on catheters as their only vascular access in 2016. This statistic highlights the clinical importance of dialysis catheters in renal care, particularly for patients awaiting fistula maturation or those medically unsuitable for surgical vascular access creation.

Emergence of Home-based Catheterization to Propel Market

Because a growing number of dialysis patients prefer treatment at home, catheters are increasingly being utilised in home settings. As a result, dialysis equipment manufacturers concentrate on developing self-dialyzing devices and services to facilitate catheterization in the home. Self-catheterization is being encouraged by medical professionals in order to reduce the expense and length of hospitalisation as well as the danger of infections contracted in hospitals (HAIs).

RESTRAINING FACTORS

Several Side Effects and the Presence of Alternatives to Hamper the Market Share

There are various side effects related with hemodialysis treatment, including itching, infections, anaemia, pericarditis, hyperkalemia, hypotension, hypertension, muscular cramps, and bone disorders. Other long-term dangers of hemodialysis include insufficient waste filtration, the creation of clots in the dialysis graft or fistula, and the emergence of cardiovascular disease or cardiac arrhythmias. People avoid hemodialysis because they are afraid of the consequences. However, the advent of other therapeutic alternatives for vascular access, such as AV fistulas and AV grafts, has slowed the worldwide dialysis catheter market growth.

• According to the Centers for Medicare & Medicaid Services (CMS) dialysis monitoring data, peritoneal dialysis catheter infections occurred at a rate of approximately 2.70 infections per 100 patient-months in 2022. The presence of infection risks associated with catheter use often encourages clinicians to transition patients toward alternative vascular access such as fistulas or grafts, which can limit the long-term adoption of dialysis catheters.
• According to the USRDS dialysis access statistics, about 58.6% of prevalent hemodialysis patients used arteriovenous fistulas, compared with 23.6% using catheters. Clinical guidelines often recommend fistulas as the preferred long-term access due to lower complication rates, which restrains the prolonged use of dialysis catheters in many treatment protocols.
• Download Free Sample to learn more about this report

•  

DIALYSIS CATHETER MARKET REGIONAL INSIGHTS

North America to Rule Out the Market With a Well Established Healthcare and Advancements

Owing to the increasing frequency of renal disorders, the expanding prevalence of diabetes and hypertension patients, and improved technology in the healthcare industry, North America leads the global dialysis catheter market, accounting for the biggest market share in 2018. The United States accounts for approximately 85% of the global hemodialysis equipment market. B. Braun Melsungen AG, Baxter International Inc., and Fresenius Medical Care are the biggest companies in North America. Because hemodialysis is the most widely acknowledged treatment modality in the country, the U.S. is considered the world's largest market for hemodialysis equipment. To grow their dialysis catheter market share, hemodialysis service providers in the country are implementing measures such as product technology and product line extension. With the technological factors and well established healthcare North American region will dominate the market in the projected timeframe.

KEY INDUSTRY PLAYERS

Prominent Manufacturers to Contribute Towards Expansion of Market

The report is an extensive research which presents the historic and futuristic performance of industry with competitive landscape analysis which incorporates prominent key players, and revenue trends of industry. The report provides substantial analysis of company profiling, growth insights, supply-demand chain, production and consumption demand, business expansion strategies adopted by top key players. The information is a collusion of latest technological developments, trends, production lines mergers and acquisitions, market study and other factors.

• Medtronic (U.S.): Medtronic is a major manufacturer of vascular access technologies and dialysis-related medical devices. The company operates in over 150 countries and supports healthcare providers with more than 95,000 employees globally. Medtronic’s vascular access portfolio includes multiple dialysis catheter solutions designed for high blood-flow rates, antimicrobial protection, and improved tip configurations for hemodialysis procedures.
• C.R. Bard (U.S.): C.R. Bard, now part of Becton, Dickinson and Company (BD), has been a significant contributor to the dialysis catheter segment through its Bard Access Systems division. BD operates in over 190 countries and employs more than 70,000 people worldwide, and its product portfolio includes tunneled hemodialysis catheters, central venous catheters, and vascular access technologies used in dialysis centers and hospitals.

List of Top Dialysis Catheter Companies

• Medtronic (U.S.)
• C.R. Bard (U.S.)
• Medline Industries (U.S.)
• AngioDynamics (U.S.)
• Amecath (Egypt)
• Argon Medical Devices (U.S.)
• Baxter International (U.S.)
• Merit Medical Systems (Jordan)
• Teleflex (U.S.)
• Kimal (U.S.)
• Navilyst Medical (U.S.)
• Jiangxi Sanxin Medtec (China)
• Guangdong Baihe Medical Technology (China)
• Shenzhen Shunmei Medical (China)

REPORT COVERAGE

The report anticipates a detailed analysis of the global market size at the regional and national level, the segmentation market growth and market share. The prime objective of the report is to help user understand the market in terms of definition, market potential, influencing trends, and the challenges faced by the market. Analysis of sales, the impact of the market players,  recent developments, opportunity analysis, strategic market growth analysis, territorial market expansion, and technological innovations are the subject matter explained in the report.